Warren Buffett’s Berkshire Hathaway is making waves again with its latest investment updates. The company’s 13F filing for the quarter ending December 31, 2024, dropped on Friday, giving investors a peek into what the Oracle of Omaha has been up to. And as always, the market took notice.
The headline-grabber? Berkshire made a fresh bet on Constellation Brands (NYSE:STZ), the beverage powerhouse behind favorites like Corona and Modelo. Buffett’s firm snapped up 5.62 million shares during the quarter, a move worth $1.24 billion. Investors wasted no time—Constellation’s stock shot up 6% in after-hours trading on Friday after the news. That’s a welcome bounce for a stock that’s been struggling, down nearly 26% this year before Buffett stepped in.
But that’s not all. Berkshire also made some adjustments to its bank holdings. It slashed its stake in Citigroup (NYSE:C) by a massive 74%, cutting it down to 14.6 million shares. And even Bank of America (NYSE:BAC), a longtime favorite in Buffett’s portfolio, saw a trim—down 15% to 680.2 million shares.
Over in the tech space, things stayed steady. Berkshire held on to its 300 million shares of Apple Inc. (NASDAQ:AAPL)—no buying, no selling. That’s a bit of a breather after Buffett had been paring back his Apple position throughout 2023. For context, Berkshire held 790 million Apple shares at the end of 2023, so this pause might signal that Buffett is comfortable with his current stake.
One more cut caught attention—Berkshire trimmed its position in DaVita HealthCare (NYSE:DVA), a kidney dialysis provider, by roughly $32 million.
Now, it’s worth noting that this data is from 45 days ago, reflecting positions as of the end of December. But Buffett’s reputation as a long-term, steady-handed investor means that any move he makes carries weight. When Berkshire shifts gears, investors listen—and often follow suit. After all, it’s not every day you get a glimpse into the mind of one of the most successful investors of all time.
